<DOC>
	<DOCNO>NCT02937077</DOCNO>
	<brief_summary>Background : Different study real-life data randomize controlled trial show detection rate paroxysmal atrial fibrillation ( AF ) 10-20 % patient cryptogenic stroke use insertable continuous cardiac monitoring 6 month . More study need , however , identify factor use select patient possibility detect AF prolong rhythm monitoring high , evaluate best duration rhythm monitoring , determine optimal deﬁnition short-term AF warrant intervention evaluate whether intervention result improve clinical outcome . Methods : The NOR-FIB study multi-centre prospective observational trial , design evaluate detection AF cryptogenic stroke transient ischemic attack ( TIA ) . Patients admit cryptogenic stroke TIA stroke unit Nordic country , age 18-80 year include Reveal LINQ® Insertable cardiac monitor system implant 12 month purpose AF detection . Biomarkers may identify patient , could derive clinical benefit detection AF prolong monitoring , study . Conclusion : This NOR-FIB study increase knowledge regard occurrence AF patient cryptogenic stroke TIA potentially improve secondary prevention . The study provide information biomarkers may use select cryptogenic TIA stroke patient long-term monitoring well information significance short-term AF optimal duration cardiac rhythm monitoring .</brief_summary>
	<brief_title>Atrial Fibrillation Cryptogenic Stroke TIA</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Cryptogenic ischemic stroke patient symptomatic TIA &lt; 21 day symptom start . 2 . A stroke/TIA consider cryptogenic cause determine despite extensive workup accord standard protocol participate center . Before inclusion study , follow test require standard test establish diagnosis cryptogenic stroke TIA : 1 . Brain MRI CT† 2 . 12lead ECG AF detection 3 . 24h ECG monitoring AF detection premature atrial complex analysis ( e.g . Holter ) 4 . TEE ( transesophageal echocardiography ) highly recommend TTE ( transthoracic echocardiography ) 5 . Colour Duplex ultrasound examination precerebral artery 6 . CTA MRA head neck rule cause stroke pathology 3 . Age 18 80 onset TIA/stroke 4 . A participation consent form sign patient legally authorize representative . TIA case acute nonlacunar infarct Diffusion Weighted Imaging include TIA event . 1 . Known etiology TIA stroke . 2 . TIA without documented cerebral ischemia Diffusion Weighed Imaging . 3 . Untreated hyperthyroidism 4 . Myocardial infarction less 1 month prior stroke TIA . 5 . Coronary bypass graft less 1 month prior stroke TIA . 6 . Valvular heart disease require immediate surgical intervention . 7 . History atrial fibrillation atrial flutter . 8 . Patent Foramen Ovale ( PFO ) PFO indication start oral anticoagulation 9 . Permanent indication OAC treatment enrollment . 10 . Permanent contraindication OAC . 11 . Life expectancy less 1 year . 12 . Pregnancy 13 . An indication Implantable Pulse Generator ( IPG ) , Implantable CardioverterDefibrillator ( ICD ) , Cardiac Resynchronization Therapy ( CRT ) implantable hemodynamic monitoring system . 14 . Patient otherwise eligible study adherent followup ( e.g . nonresident ) concurrent disease may affect clinical outcome ( e.g . multiple sclerosis , cancer ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>etiology</keyword>
</DOC>